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Report Summary: This report provides an overview of the collaborative research between the Dr. Ali 
Adibi from Georgia Institute of Technology and Dr. Richard Cummings from Emory University for 
development of label-free Glycan arrays that can be used toward the detection of cancer specific 
biomarkers for different cancers, specifically alternative biomarkers for prostate cancers. The goal of this 
program was to develop initial proof of concepts for glycan arrays to promote larger size program from 
Federal funding agencies. The proposed microarray or multiplexed sensing platform is based on an array 
of compact resonators each coated with a different molecular probe that can target different set of glycan 
binding protein (i.e., lectin) biomarkers. During this program, Adibi and Cumming groups worked 
closely to demonstrate multiplexed sensing platform based on array of compact resonators coated with 
different set of glycan surface coatings. To achieve this, during this project several important challenges 
from the design of the sensor array and developing of the surface functionalization protocols to the 
design of optimal microfluidic channel and development of optimal technique for accurate measurement 
of the resonators resonance wavelength shift have been addressed. The outcome of this one-year project 
sets the stage for the future work for cancer biomarker discovery and cancer detection device and 
systems. Adibi and Cummings are working closely to apply these results and finding of this project in 
new problems and have submitted several joint proposal to the federal funding agencies (especially NIH) 
including one for development of a new technique for prostate cancer detection based on identification 
of the glycan group of the prostate specific antigen (PSA) using the developed multiplexed sensing 
platform.        
Introduction: Prostate cancer is one the most commonly diagnosed cancers in males in the United 
States and ranks second among tumor site-specific mortality, with estimates for 2009 at over 192,000 
new cases and 27,000 deaths [1]. A major advance in screening for prostate cancer was the identification 
of the prostate specific antigen (PSA), a biomarker test that has resulted in an increased incidence of 
diagnosed prostate cancer.  While the PSA test is widely used and is quite sensitive, it is not highly 
specific and there is an unmet and very important need to develop new biomarkers for more accurately 
discriminating prostate cancer from benign disease states.  Moreover, there is also growing evidence that 
tumor cells in general exhibit altered glycosylation of surface glycoproteins and glycolipids in the so-
called glycocalyx [2].  These altered molecules released from tumors may be immunogenic and stimulate 
T- and B-cell dependent immune responses with the development of anti-glycan antibodies. Such anti-
glycan antibodies generated against tumors afford a novel biomarker opportunity for study. However, a 
major challenge that has stymied the development of such anti-glycan antibody assays is the lack of 
suitable highly sensitive and robust strategies for detecting such tumor-specific anti-glycan antibodies. 
Glycan microarrays based on a secondary fluorescent label are currently being used for many 
applications; however, they require finding an appropriate label that functions uniformly with all of the 
desired antibodies. This is especially difficult in this case as the target autoantibody is not known before 
the detection. Label-free glycan microarrays resolve this issue as they do not require any secondary 
labeling.  
The main goal of this work is to develop a label-free glycan microarray based on a densely 
multiplexed array of refractive index sensors.  Such glycan microarray enable to detect the main 
autoantibodies that are produced by humans for the cancer specific glycan antigens. Once unique glycan 
antigens are identified, they may be used to generate specific monoclonal antibodies to tumor cell 
glycans that will be useful in targeting therapeutics to the tumors.  
Our main focus in this project has been on developing a label-free resonance-enhanced glycan-
functionalized microarray or multiplexed sensing platform and optimization of the performance and 
sensitivity of it. To achieve this, several different tasks have been done to 1) develop a multiplexed 
sensing platform based on a resonator array, 2) develop the required surface chemistry for binding of the 
glycan surface coating to the surface of the sensing elements, 3) design and implement the required 
sample delivery system to optimize the input analyte interaction with the sensing elements, 4) 
development of accurate resonance wavelength shift measurement to achieve high sensing sensitivity, 
and 5) testing of the developed sample for different target analyte to demonstrate the overall 
performance of the system. Furthermore, we have developed different techniques to improve the 
sensitivity of the developed sensing platform based on developing sensors with porous surface and 
integrating the developed sensor array with microfluidic systems for sample  pre-concentration. This 
report provide a summary and high-light of the research done under this project. 
1) Development of a multiplexed label-free microarray  
1.1) Introduction: A resonator-based refractive index sensor is a label-free sensor that detects the target 
analytes by monitoring the changes in the resonance wavelength of the resonator, caused by the analyte 
binding to the resonator surface. High-Q resonators provide high sensitivity to the changes in the 
refractive index of their surrounding environment, as a small shift in their resonance wavelength leads to 
a considerable change in their transmission characteristics, at wavelengths close to their resonance 
wavelength. A resonant-based refractive index sensor in its simplest form is a waveguide-coupled 
resonator or a Mach-Zehnder (MZ) interferometer with a resonator coupled to one or both its arms. 
Figure 1 shows the schematic of a resonator-based refractive index sensor. The shift in the resonance 
wavelength manifests itself in the changes in the transmission of the sensor device and can be estimated 
by measuring the changes in the device transmission at a certain wavelength or over a range of 
w a v e l e n g t h s .  
 
Figure 1: Schematic of the refractive index sensing by measurement of the resonance shift of a resonator caused by the 
analyte binding to the resonator surface. By biasing the input laser at a wavelength with maximum transmission slope, a 
small shift in the resonance wavelength of the high-Q resonator translates to a large change in the transmission 
amplitude. 
 
1.2) Multiplexed sensing: A highly-multiplexed refractive index sensor can be implemented by 
integrating a large number of ultra-compact resonator-based sensors on the same chip. This multiplexing 
can be done either in the spectral or in the spatial domain. In spectral domain multiplexing, many 
resonators, each with a different resonance wavelength, are coupled to the same input waveguide to form 
a resonator array (see Figure 2). The resonant wavelength of each resonator is adjusted by engineering its 
geometry (i.e., inner and outer radii). Each resonator is coated with a different surface coating to most 
specifically detect a certain analyte. Each individual resonator in the array can be interrogated 
independently by monitoring the transmission through the waveguide at the wavelength range 
corresponding to the resonance of the desired resonator. 
 
 
Figure 2: (a) Schematic of a multiplexed refractive index sensor composed of several different resonators, each 
at a different resonance wavelength, coupled to a common bus (or interrogating) waveguide. The resonance 
wavelength of each resonator is adjusted by engineering its geometry (i.e., inner and outer radii). Each 
resonator is coated with a different surface coating to specifically detect a certain analyte. (b) and (c) show the 
transmission spectrum of the resonator array before and after exposing to the target input sample. Different 
resonance shifts of different resonators indicate the different degree of binding to analytes in the input sample. 
 
In the spatial domain multiplexing, an array of separate waveguide-coupled resonators is used. The 
resonator in this case can be designed to have similar resonance wavelengths. In this case, to interrogate 
each sensor, the output signal of its corresponding waveguide should be measured. The main advantage 
of the spectral domain multiplexing is that all sensing elements can be interrogated using a single pair of 
input and output. However, the maximum number of sensing elements that can be multiplexed in the 
spectral domain is limited by two important factors: 1) the minimal required resonance wavelength shift 
of each resonator for successful binding detection, and 2) the maximum free-spectral range (FSR) of the 













































the miniaturized microdisk resonators with world-record performance in silicon on isolator (SOI) 
platform. These resonators combine a large single-mode FSR and a high Q that is optimum for a large 
multiplexing degree. For example, using microdisk resonators with a radius of 2μm and a FSR of ~ 54 
nm, and assuming a maximum required resonance wavelength-shift dynamic range of 600 pm for each 
sensor element, up to 90 different sensors (or resonators with proper surface coating) can be multiplexed 
and coupled to the same waveguide. A larger multiplexing degree can be obtained by combining spectral 
and spatial multiplexing (e.g., an array of waveguides each coupled to an array of resonators. 
 
1.3) Development of the microarray on SiN on oxide platform: 
While the high refractive index contrast of Si in respect to oxide enables to achieve very compact 
resonators wit h very large FSR, silicon nitride (SiN) material platform provides certain advantages 
including the much lower temperature sensitivity due to smaller thermo-optic coefficient, higher power 
handling due to lack of two-photon-absorption and smaller third-order nonlinearity,  and low absorption 
at visible and NIR wavelengths that enables to implement the microarray at visible wavelength where we 
get much lower water absorption and we can multiplex the refractive index sensing with other modalities 
such as fluorescent and Raman sensing. Therefore, we have focus most of our efforts on developing the 
microarray on SiN platform. While SiN due to its smaller refractive index may not provide FSRs as high 
as those that can be achieved by SOI platform, a combination of spatial and spectral multiplexing can be 
used to compensate for this. The availability of chip high quality detector arrays and CCDs at visible and 
NIR wavelengths enables to implement low cost microarrays based on CCD detectors. Figure 3 
demonstrates as example of fabricated microarray on SiN platform. The devices has been fabricated and 
processed at Georgia Institute of Technology’s cleanroom facility. Cleaved pieces of the wafer are 
cleaned by acetone, methanol, and isopropanol rinse.  The chips are dehydrated for five minutes of at 
100C on hotplate and spin coated after cooling. ZEP520A is spun at 1500 RPM for 1 minute, and then 
baked at 180C for two minutes. Coated chips can be kept in a dark place for a few weeks. Right before 
electron beam lithography (EBL), ESPACER was spin coated at 4000 RPM for 30 seconds on the 
pieces, to reduce charge-up effect. Device patterns are written using JEOL JBX-9300FS EBL System 
into ZEP, with a current of 2 nA and dosage of 200 µ C/cm 2. Before developing, the chips are rinsed 
with running deionized (DI) water for 1 minute to wash the ESPACER layer.  Next they are developed in 
amyl acetate for 2 minutes with gentle agitation, and then soaked in isopropanol for 30 seconds. Dried 
chips are etched in Oxford endpoint RIE etcher using CF 4 plasma (20 sccm CF 4 flow, 200 W power, 
10 mTorr pressure).  Residual ZEP is removed after the etch by soaking the chips in Microposit remover 
1165 at 80C for 20 minutes, followed by acetone rinse. The chips are cleaned in Piranha (5:1 H 2 SO 4 
and H2O2 ) for 10 minutes and then rinsed with DI water. 
Figure 3.a shows the layout of the developed SiN multiplexed resonator array, Figure 3.b shows the 
schematic of the resonators in each row showing the sensing and reference (Coated by SU8) resonator, 
and Figure 3.c shows the top microscope image of the fabricated sample with opening in cladding SU8 
material for sensing elements. In this sample on each row we have provided two reference and three 
reference resonators that can be coated with different glycans. A large number of sensing element can be 
achieved by using multiple sensing lines (Figure 3.a). 
To characterize the fabricated sensors, the transmission spectra of the fabricated resonator array is 
measured. Focused laser light is side-coupled to the waveguides at the edge of chip.  Laser source is a 
New Focus TLB 6305 tunable laser module sweeping 652-660 nm window.  Laser’s output is 
conditioned by a half-wave plate and a polarizing beam splitter to rotate the polarization of the laser 
output onto TM direction and suppress the TE component.  The device is aligned to have the edge of the 
input waveguide in the focused laser beam.  On the other end, another lens is used to project the output 
light onto a silicon detector.  Collected spectral data is analyzed for detecting the resonances and fitting a 
Lorentzian to the detected resonances. Figure 4 shows the schematic of the transmission spectra of the 
resonators on one of the rows at wavelengths between 650 nm to 660 nm measured by using a detector 
that collects the light from collected by a top detector. Each peak at this image corresponds to one of the 
resonance wavelength of one of the reference or sensing resonator. Therefore the binding to the 




Figure 3: The schematic of a developed SiN multiplexed resonator array. (a) The designed lay out of the sensor 
array. (b) The schematic of the resonators in each row showing the sensing and reference (Coated by SU8) 
resonator. (c) The top microscope image of the fabricated sample with opening in cladding SU8 material for 
sensing elements. (d) SEM image of one of the resonators in the array. 
 
2) Development of surface chemistry protocols for the glycan microarray 
After the development of the surface of the sensing elements are coated by different glycan surface coating. In 
order to increase sensitivity and also specificity of photonic sensors, we modify the surface of the sensor by 
grafting cognate receptor of target ligands. This surface modification is slated to capture target cells or molecules 
and thus considerably enhance the sensitivity by increasing the density of target on the surface. Also this surface 
chemistry is designed to suppress non-specific binding 
of competing targets to the surface, which boosts the 
specificity of the sensor. Glycans provide a viable 
platform for sensing, as they provide a wide range of 
receptors that can distinguish between many different 
targets (e.g. toxins) using a panel of glycans in the form 
of microarray [3]. In our scheme, we immobilize 
glycans on the sensor microarray, and detect binding of 
target anaylte using the sensing platform. Employed 
glycans are derivatized to include amine moiety on their 
surface. Thus by grafting carboxylate group on the 
sensor surface glycans can be fixed on the surface using 
a strong peptide bond. First step of this surface 
chemistry on silicon, silicon dioxide, or silicon nitride 
starts with alkoxysilane end-group in order to graft a 
self-assembled monolayer on the surface. Most 
conventional procedure is grafting of 3-
aminopropyltriethoxysilane (APTES) which provides 
amino group, and then application of NHS-EDC 
chemistry to the Si-APTES surface [4]. In order to 
suppress non-specific binding it is customary to 





Figure 4: The characterization results of the resonator 
array in SiN platform. Different peaks correspond to 




glycol) chains under receptor layer. In above mentioned chemistry this can be done by using PEG bearing amine-
amine linker, like Bis(succinimidyl) nona(ethylene glycol), instead of NHS-EDC chemistry. Tween-20 [5] and 
BSA [6] has also been used for prevention of non-specific binding. Finally we immobilize our glycans by 
incubating them on aminated substrate.  
We start by degreasing and cleaning the substrate by rinsing the sample using acetone, methanol and isopropyl 
alcohol. Next sample is soaked in Piranha solution (3:1 H2SO4, 30% H2O2) for 15 minutes, for cleaning and 
activation of hydroxyl groups on the surface. Then sample is immersed in 1%w/v silane-PEG-NHS [7] (Figure 5) 
in dry DMSO, for 5 hours at room temperature. Afterwards sample is rinsed with dry DMSO and dried using 
nitrogen blow. At this stage sample is PEGylated and aminated. Glycans are then spotted on specific locations and 
sample is incubated at 50C for one hour. When incubation is done, the sample is let dried and washed in PBS with 
0.05% tween-20 and then is washed in ddH2O. Blocking is done by immersion in 50mM ethanolamine in 50 mM 
sodium borate (pH 8.0) for 1 hour. Afterwards same washing protocol is applied to remove any chemical residues. 
To evaluate the performance of the developed surface coating protocol for the SiN surface, we first performed the 
process to coat the surface of a SiN sample with a few different glycan and test the binding with different lectins. 
Figure 6 shows that fluorescent image of the binding between different fluorescent tagged lectins and different 
glycan surface coating and the binding strength can be evaluated by measuring the emitted fluorescent signal. The  
binding strength in this case matches with the expectations and this verifies the reliability of the developed surface 
coating process. 
 
Figure 5: (a) Schematic of binding PEG and NHs to SiN surface using single step process using Silane-PEG-
NHS molecule(b) Examples of the binging  Specificity for the protein on a virus surface: Simian Virus 40.  
 
We then used the same surface coating process to coat the surface of different resonator in the developed resonator 
array. We have used different physical methods for applying the coatings to the small area transducer surfaces 
using the deposition tools available at the Georgia Tech NRC. The Nano eNabler (Bioforce Nano) is a 
multifunctional surface patterning tool that can be used for precise selective coating of the sensor surface. It 
enables dispensing attoliter to femtoliter volumes of biomolecules, nanoparticles and other liquids onto a wide 
variety of surfaces. Using a grooved cantilever surface patterning tool, we have been able to pattern drop sizes with 
down to 3 μm diameter with very high alignment accuracy. Alternatively, ink-jet printing (Microfab jetlab II) can 
produce drop-on-demand as small as 10 μm diameter.  
After the coating of the resonator surface, the binding kinetic between the surface coating glycan and the lectins 
can be measured using the developed label-free refractive index sensor. Figure 7 shows the changes in the 
resonance wavelength of the resonator versus time, caused by the binding of the ConA molecules to the resonator 
surface coated by Man5 Glycan. A maximum shift of 30 pm is observed for the addition of 20 uL of a streptavidin 
solution with a concentration of 10μg/mL in a reservoir, already filled with 20 uL of buffer solution  on top of the 
sensing resonator. Because of the high concentration of the ConA solution in this experiment, we expect that all the 








Figure 6: (a) The test of the surface binding of different lectins to the coated glycans using the dev eloped 
surface chemistry on the SiN surface. 
 
3) Development of Multiplexed Sensing Platform  
To study the performance of the sensor for the detection of a mixture of proteins, we have used 3FL and 
2,6-NA2 glycans as surface receptors, to detect and quantify the concentration of Aleuria Aurantia 
Lectin (AAL) and Sambucus nigra lectin (SNA). Each glycan/protein pair is tested individually at first, 
in order to estimate the binding dynamics of the pair. This test is carried out by immobilizing one glycan 
on three sensing rings, while leaving the other three sensing rings un-coated (i.e., having only the PEG 
brush). The corresponding protein with various concentration is applied to the sensor the dissociation 
constant (KD) is measured from the dose-response curve. In the  next test, each of the two glycans are 
immobilized on two different sensing rings, leaving the remaining two microrings (out of six) un-coated. 
Two mixtures of these two proteins are prepared (a low-concentration and a high concentration mixture), 
and applied to the sensor sequentially.   
We use the high concentration phase to calculate the saturation response (R0) as: (R0 = RH (CH+KD)/ 
CH),  where RH is the high concentration response (defined as the shift at the end of high concentration 
phase), CH is the high concentration of the lectin being studied, and KD is the dissociation constant of 
the glylcan/lectin pair being studies. Subsequently, the concentration of the low-concentration phase is 
estimated using, C = R0 CL/(CL+KD). Figure 8.a shows The result of multiplexed sensing of the two 
proteins. The experiment is repeated on two 
similarly prepared sensor chips. Resonance shift 
of the ring  sensors with 3FL (blue) and 2,6-
NA2 (green) glycans coating to low-
concentration (CL) and high-concentration 
(CH) mixtures. 
4) Development of more efficient technique 
for the measurement of the resonance shift 
 
The perturbation of resonance caused by 
biological or chemical molecules at the vicinity 
of a resonator has proven to be a sensitive 
trnasduction mechanism for lab-on-chip sensors 
[8,9]. For an individual on-chip resonator with a 
linear response, the limit of detection (LOD) is 
defined as, LOD = 3σ/S, where S is the 
sensitivity, and σ is the standard deviation of 
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Figure 7: The characterization results of the resonator 
array in SiN platform. Different peaks correspond to 
different sensing and reference resonators in the array.  
 






















Resonator Response. Man5 and ConA
output fluctuations (resonance shift here) for blank input. Smaller LODs are achieved either by the 
enhancement of device sensitivity (S), or through the improvement of detection accuracy (by reducing 
3σ). Although an increase in device sensitivity can compromise other system performance measures, 
such as multiplexing capability within a fixed wavelength window, an improvement in the detection 
accuracy does not cause such compromises. Improving this accuracy in applications relying on highly 
multiplexed arrays entails maintaining a homogeneous performance across a wide bandwidth of scan. In 
this sense, although for small dynamic ranges high accuracies may be readily achieved by simple 
interrogation systems, the same system does not necessarily help highly multiplexed systems scanning a 
wide window of wavelength. We have developed a new interferometric referencing method that 
remarkably suppresses wavelength noise, and thus improves the resonance detection accuracy across an 
8 nm window of scan. No temperature control is used, and by taking the advantage of sub-periodic 
interferometric data an improvement by more than one order of magnitude is realized. Next section 
presents the device, the interferometric referencing method, and the experimental results. 
 
 
Figure 8, The result of multiplexed sensing of the two proteins. The experiment is repeated on two similarly 
prepared sensor chips. Resonance shift of the ring  sensors with 3FL (blue) and 2,6-NA2 (green) glycans 
coating to low-concentration (CL) and high-concentration (CH) mixtures.  
 
We have employed silicon nitride microring resonators on a silicon dioxide substrate, working at 
visible wavelength [10]. Five such microrings with a width of 500 nm and an outer radius of 20 mm 
(FSR = 1.65 nm) are coupled to a common bus waveguide as illustrated in Figure 9 (a). The laser light is 
coupled to the waveguide at the edge of the chip and the intensity of output light is recorded using a 
silicon detector. A NewFocus external cavity diode laser (linewidth < 300kHz) is used for scanning the 
wavelength in 652-660 nm window, as illustrated in Figure 9 (c). A sample of the recorded spectrum is 
demonstrated in Figure 9(b). 
In order to compensate for temperature variations, and also laser wavelength drifts from one scan to 
the next, we measure the resonance shifts differentially (i.e., subtract the detected resonance of a second 
microring from that of the microring intended for sensing). We consider 20 resonances in the 8 nm 
window of scan for our study here (four azimuthal modes of each microring). For an undisturbed setup, 
the standard deviation of differential resonance shifts, calculated from 60 consecutive scans of the 
spectrum, is σ = 585 fm. 
One potential source of these variations in the detected resonance is the amplitude noise of the 
transmission signal detected at the detector. Thermal and shot noises, either on the laser output or at the 
detector, contribute to this noise. Furthermore, we have observed electrical interferences, and mechanical 
vibrations at coupling points, to affect the signal-to-noise ratio (SNR). The amplitude noise or reasonable 
thermal variations, as it will be discussed in this talk, cannot cause the above mentioned variations in the 
detected resonance. 
Beside the amplitude noises, the inaccuracy of the tunable laser in setting the wavelength introduces 
an independent source of noise. In order to accurately measure the wavelength and correct such 
wavelength deviations, we used a free-space Michelson interferometer, depicted in Figure 9 (c). 
The scan of the 8 nm window is repeated 60 times, and two detection algorithms, with and without 
using the interferometer data, are compared on this data set. In the detection method without the 
interferometer, the wavelength is assumed to change linearly across the scan window. So the sampling 
times are linearly scaled to calculate the wave-length at each sampling point. However, in the detection 
method using the interferometer we correct the wavelength for each data point based on the 
interferometer recording. After extracting the wavelengths, a second order polynomial is fit to 200 data 
points around the minimum point of the transmission (sampling rate is 20 fm). For the SNR of this setup, 
this second order fit suffices, compared to more complex fits such as Lorentzian. 
We have demonstrated the probability distribution function constructed from one of the pairs in 
Figure 10(a). This representative figure demonstrates how the application of the interferometric 
correction suppresses the variations. The statistical analysis for all resonance pairs (excluding same 
microring pairs) results in σavg = 41 fm using the interferometer, which shows more than one order of 
magnitude improvement compared to σavg = 585 fm without the interferometer, as illustrated in Figure 
10(b).  
 
Figure 9. (a) The SEM of the microring. (b) A sample of the measured spectrum. (c) The schematic of the 
characterization setup. 
 
Figure 10. (a) Measured probability distribution function of detected resonance shifts with and without the 
interferometric referencing. (b) The histogram of the improvement ratio. σ0 is the standard deviation 
without interferometer, and σint is that with the interferometer data; first calculated for each resonance pair 
and then entered to the histogram. 
 
 
5) Development of porous-cladding sensing platforms 
To increase the sensitivity of the proposed sensors, we fabricate a thin layer of porous material on 
top of the resonators (porous Si on top of Si devices and porous TiO2 on top of SiN devices). Figure 11 
shows examples of a micro-resonators with a porous Si and TiO2 cladding, fabricated in Adibi's group. 
The highly controlled thin porous Si is fabricated by converting a thin layer of oxide to porous Si based 
on magnesium reduction of oxygen in SiO2 [11]. The thin porous TiO2 layer is fabricated using sol-gel 
technique using sacrificial protamine-carboxyl spheres to control the pores size [12, 13]. The advantage 
of the proposed techniques over conventional porous structures [14,15,16] is the possibility of achieving 
a large effective surface area for sensing while maintaining high Q in compact resonators to achieve 
orders of magnitude higher sensitivity with a very compact device. Our experiments show an 
enhancement factor of six and ten for the sensors with porous Si and porous TiO2 claddings 
corresponding to mass sensitivities of 0.06 pg/mm
2
 and 0.016 pg/mm
2
 (assuming a resonance 
wavelength sensitivity of 0.04 pm ), respectively. (See  Figure 11). 




6) New approached for the analysis of PSA 
 
While the main goal of this program has been to develop glycan microarray for detecting new 
biomarkers for prostate cancer in blood, we have also looked at possibility of looking at structure of PSA 
itself (rather than only its concentration) as a specific biomarker for prostate cancer. Adibi an dcumming 
group so have been working actively on developing new approaches for detecting prostage cancer and 
submitting proposals for federal funding agencies based on this ideas. 
 
PSA is a small 33kDa heavily glycosylated glycoprotein (~8% carbohydrate by weight) [17], but 
contains a single Asn-glycosylation (N-glycan) site [18] that presents heterogeneous “glycoforms”  
[19,20,21,22,23,24]. Several recent studies have focused on studying these various glycoforms of PSA as 
a biomarker for prostate cancer. Such studies demonstrate that there are different glycoforms present that 
have varying amounts of fucose, N-acetylgalactosamine, sialic acid, and altered and often increased N-
glycan branching. Furthermore, analysis of glycoforms of PSA from normal and from the prostate cell 
line LNCaP revealed major differences in their glycan structures, reflecting the changes in glycosylation 
pattern that usually take place on the tumor cells [25, 26]. Therefore, we hypothesize that the expressed 
Figure 11, (a) SEM of a racetrack resonator with porous silicon cladding; (insets) close-up image and cross-
section images shows uniform porous silicon layer with pore size of 20~30 nm. (b, c) Comparison of 
resonance wavelength drifts after surface coating with APTES (blue) and Biotin (red). The black curve show 
the original resonance spectrum. (b) Reference SOI resonators; (c) Porous silicon resonators. A factor 6 
improvement in resonance wavelength shift is observed (672 pm for porous sample as compared to 112 pm 
for  .the sample without cladding. The measurement are done for dried samples. (d) SEM of a SiN  microring 
resonator with porous TiO2 cladding, (e) and (f) the resonance shift with APTES coating for microring 
resonator without and with porous cladding, respectively. The porous TiO2-cladd sensor demonstrates more 
than one order of magnitude enhancement in shift selectivity with a high Q of 60 k.      
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and different glycoforms of PSA in serum represent a novel biomarker that can distinguish benign from 
malignant PCa and may reflect on the stage of the cancer.   
Currently, the typical laboratory test for PSA measure the free and/or total PSA using a 
Immunochemiluminometric Assay (ICMA).  This approach cannot identify the glycoforms of PSA, 
which currently can only be indirectly studied using mass spectroscopy (MS). However, isolation and 
detailed chemical characterization of PSA from patient serum using MS and other available techniques 
are impractical, and do not identify the specific glycoforms structure, only size, and in any case are not 
accessible to common laboratory practices, given the extremely low amounts of PSA in circulation 
(ng/mL) and the need to analyze so many different samples to allow firm conclusions to be drawn from 
both quantitative and qualitative data.  
Therefore, we believe that it is possible to develop a new low-cost molecular analysis technique for 
the identification and quantification of different PSA glycoforms. This technique will provide a very 
high level of sensitivity (LOD ~ 10 pg/mL) with an easy-to-use and rapid assay process that requires 
very small volumes of input sample (i.e., a few μL). This technique is label-free and allows a definitive 
test of our hypothesis by identifying and measuring different glycoforms of serum PSA and defining 
their correlation with the presence and stage of PCa and discrimination of BPH from PCa.  
This proposed biomarker screening technique is based on the same developed multiplexed sensing 
platform developed in this project. However, here we use a two -step process to: 1) filtered and pre-
concentrated by capturing it on an anti-PSA functionalized surface; and 2) the captured, and eluted PSA 
is screened for specific glycoforms both quantitatively and qualitatively using a specialized lectin- and 
anti-glycan-based microarray (Figure 12). We will prepare PSA glycoforms as standards in which the N-
glycans have a wide variety of glycan structures of the types reported by Tabares et al (2006) 
[27,28,29].  However, the chemical quantities of PSA in human serum are below the limit required for 
detailed N-glycan sequence analyses, so little is known about all the types of N-glycans present and 
primarily indirect methods are used [30].   
The possibility of screening a large panel of PSA glycoforms provide a large amount of useful 
information that can be used to develop clinical methods for early detection of prostate cancer as well as 
diagnosis/monitoring of the prostate cancer stage/progress. Therefore, we are looking toward the 
demonstration of the performance of the proposed device for accurate and reliable quantification of 
concentration of different PSA glycoforms using a series of controlled test samples and a limited number 
of de-identified samples from patients with PCa and PBH. Such device and screening technology enables 
new extensive clinical studies on the use of PSA 
glycoform information for patient diagnosis.   
 Figure 13 shows the schematic of the proposed 
microfluidic chip for the screening of the PSA 
glycoforms. In the first step, the PSA molecules are 
separated from the serum through affinity binding to 
the PSA antibody immobilized on the surface of a 
microfluidic channel or on the surface of 
microspheres trapped in the microfluidic channel (step 
1a). The microfluidic channel is then washed with a 
buffer solution to clean the channel form the traces of 
the undesired analytes in serum and to wash the 
nonspecifically bound molecules to the surface. In the 
second step, the collected PSA molecules are eluted 
from the antibody-coated surface, and the PSA 
Figure 12, The principal of the identifying and 
quantifying free PSA glycoforms as biomarkers 
for benign versus malignant prostate cancer. In 
step 1, anti-PSA antibodies are used to capture 
and concentrate free PSA from a serum 
sample. After washing, the captured PSA is 
released for Step 2, where its different 
glycoforms are captured by different detecting 
regents (antibodies and lectins).  
glycoforms is screened by measuring the binding pattern of PSA molecules to a panel of lectins and 
antiglycan antibodies, carefully selected to distinguish different target glycoforms and immobilized on 
top of an on-chip photonic resonator array. This process also allows for pre-concentration of the PSA by 
a relatively large factor (e.g., x100) and considerably enhances the overall detection sensitivity.  
 
A compact, sensitive, and highly multiplexed array of SiN resonators (similar to those developed in 
this project) can be used for label-free quantification of different PSA glycoform concentrations by 
measuring their resonance shift due to the binding of PSA to their surface. The SiN chip is integrated 
with the microfluidic system, which is fabricated using PDMS or glass. The chip will be pre-filled with 
all required buffers. The assay process will be controlled using pressure-driven flow control, and the 
integrated photonic microarray will be characterized by using an off-chip tunable laser and a detector 
array that are optically coupled to the chip through grating couplers on chip. The sample filtering and 
pre-concentration and the sensing microarray will be separately realized and tested to achieve the target 
performance; and then they will be integrated to form the complete screening system. We will also 
develop data processing and analysis tools that provide the concentration of different PSA glycoforms 
from the raw measurements. The sensing system will be calibrated using a series of controlled pure PSA 




7) Conclusions and Futures works: 
Our main focus in this project has been on the demonstration of the label-free microarray. We 
furthermore, developed different techniques to improve the sensitivity of the developed label-free 
multiplexed sensing platform to achieve sensitivities needed for the target application in prostate cancer 
detection. In this program, the Adibi and Cumming groups work closely to develop surface chemistry for 
functionalization of sensors surface using glycans.  The test of this sensing platform has been done with 
different available lectins that should provide similar binding kinetics to the ultimate target biomarkers. 
While we are continuing working on the improvement of the developed glycan-based multiplexed 
sensing platform (i.g., microarray), the Emory and Georgia-Tech team has also worked closely to 
develop new techniques for prostate cancer detection approach based on glycan and lectin array 
technology. The work has led to several publications and conference presentations. Here a brief list of 
the published work through this program. 
Publications: 
 
1. Ghasemi, Farshid, Ali A. Eftekhar, David S. Gottfried, Xuezheng Song, Richard D. Cummings, and 
Ali Adibi. "Self-referenced silicon nitride array microring biosensor for toxin detection using glycans 
at visible wavelength." In SPIE BiOS, pp. 85940A-85940A. International Society for Optics and 
Photonics, 2013. 
2. Xia, Zhixuan, Stan C. Davis, Ali A. Eftekhar, Ari S. Gordin, Murtaza Askari, Qing Li, Farshid 
Ghasemi, Kenneth H. Sandhage, and Ali Adibi. "Magnesiothermically Formed Porous Silicon Thin 
Figure 13, Schematic of the proposed microfluidic chip for PSA filtering and pre-concentration. The 
fluidic chips is integrated with a lectin/antibody-coated photonic resonator array for the PSA 
glycoforms screening.  
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